Medicine & Life Sciences
Erlotinib Hydrochloride
61%
Chemoprevention
54%
Myofibroblasts
41%
Phosphotransferases
37%
Pharmacology
32%
Fibrosis
27%
Liver Neoplasms
24%
Platelet-Derived Growth Factor beta Receptor
16%
Neoplasms
15%
Preventive Medicine
14%
Liver
12%
ErbB Receptors
11%
Tumor Burden
11%
Nanoparticles
10%
Hepatocytes
10%
Safety
7%
Engineering & Materials Science
Chemoprevention
100%
Liver
58%
Epidermal Growth Factor
28%
Hepatocytes
27%
Intercellular Signaling Peptides and Proteins
24%
Platelets
20%
Rats
19%
Toxicity
19%
Tumors
16%
Medicine
16%
Nanoparticles
15%
Molecules
15%
Chemical Compounds
Erlotinib
77%
Dose
18%
Effector
13%
Non Toxic
12%
Safety
10%
Reduction
5%
Molecule
4%
Surface
3%